CL-316243

CAS: 151126-84-0

Ref. 3D-BGA12684

Produktinformation

• Name: CL-316243
• Synonyme: 1,3-Benzodioxole-2,2-dicarboxylic acid, 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-, disodium salt, 1,3-Benzodioxole-2,2-dicarboxylic acid, 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-, sodium salt (1:2), 1,3-Benzodioxole-2,2-dicarboxylic acid, 5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-, disodium salt, [R-(R*,R*)]-, 5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-Hydroxyethyl]Amino]Propyl]-1,3-Benzodioxole-2,2-Dicarboxylic Acid Disodium Salt, 5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylicaciddisodiumsalt, Cl 316,243, Cl 316243 Disodium, Cl 316243 Disodium Salt, Hp 186, Sodium 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (2:1)

Beschreibung

CL-316243 is a 2-adrenergic receptor antagonist that is used to treat bowel diseases. CL-316243 binds to the 2-adrenergic receptors in the adipose tissue, which inhibits lipolysis and energy metabolism in adipose cells. This drug also inhibits the cyclase activity of adenosine 3’,5’-cyclic monophosphate (cAMP) and cGMP, which are important mediators of energy metabolism. CL-316243 has been shown to be effective in vitro against human adipocytes and may have potential as a pharmacological treatment for obesity and congestive heart failure.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 465.79 g/mol
• Formel: C₂₀H₁₈ClNNa₂O₇
• Reinheit: Min. 95%